Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Aug 31, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

413

Epigenetic engineering for optimal chimeric antigen receptor T cell therapy.

Yusuke Ito1, Yuki Kagoya1,2

  • 1Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan.

Cancer Science
|August 24, 2022
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of a shared antigen linking CD4<sup>+</sup> T and B cell pathology in Sjögren's disease.

Science advances·2026
Same author

Constitutive STAT3 Signaling, in Comparison with STAT5, Enhances CAR T-cell Efficacy and Lowers Systemic Toxicity.

Cancer immunology research·2026
Same author

Efficient expansion of tumor-infiltrating lymphocytes from gynecologic cancer.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

JAK-STAT-activated, fratricide-resistant CAR-T cells targeting membrane-bound TNF effectively treat AML and solid tumors.

Journal for immunotherapy of cancer·2025
Same author

Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity.

Journal for immunotherapy of cancer·2025
Same author

Current progress of CAR-T-cell therapy for patients with multiple myeloma.

International journal of hematology·2024

Epigenetic factors critically regulate T cell functions in cancer immunotherapy. Modifying these epigenetic regulators can enhance chimeric antigen receptor (CAR)-T cell therapy persistence and effectiveness for better cancer treatment outcomes.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Cancer immunotherapy, including CAR-T cell therapy, has advanced cancer treatment.
  • Understanding T cell molecular functions is key to improving immunotherapy efficacy.
  • Epigenetic factors like DNA methylation and histone modifications control T cell phenotypes.

Purpose of the Study:

  • To review the role of epigenetic factors in T cell biology.
  • To explore the potential of epigenetic modulation in enhancing cancer immunotherapy.
  • To discuss future strategies for integrating epigenetic findings into CAR-T cell therapy.

Main Methods:

  • Literature review of recent studies on epigenetic factors and T cell function.
  • Analysis of how epigenetic modifications impact T cell cytotoxicity, memory formation, and exhaustion.
Keywords:
CAR-T cellepigeneticsexhaustionmemory T cellterminal differentiation

More Related Videos

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.5K
Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

3.9K

Related Experiment Videos

Last Updated: Aug 31, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

413
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

1.5K
Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models
06:22

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

3.9K
  • Examination of exogenous epigenetic modification strategies for T cell enhancement.

    • Main Results:

    • Specific epigenetic genes are associated with T cell phenotypic changes.
    • Epigenetic factor manipulation can significantly alter T cell transcription networks.
    • Modulating epigenetics offers a feasible strategy to improve CAR-T cell quality.

    Conclusions:

    • Epigenetic regulation is crucial for T cell-mediated antitumor responses.
    • Targeting epigenetic factors holds promise for improving CAR-T cell therapy persistence and effector functions.
    • Future research should focus on integrating epigenetic insights for optimized cancer immunotherapy.